Categories: NewsNutrition

NextEvo Naturals Announces Improved Berry Flavor for Caliper Berry Swiftsticks

CONSHOHOCKEN, PA / ACCESSWIRE / January 23, 2024 / NextEvo Naturals (“NextEvo™” or the “Company”), a premium supplement brand focused on revolutionizing the delivery of nutritional compounds, today announced the newly improved berry flavor in their Caliper Berry Swiftstick.

NextEvo Naturals Caliper Berry Swiftsticks

Each Caliper Berry Swiftstick delivers a perfectly precise 20mg of CBD with a newly improved, delicious berry flavor that will have you feeling like a kid again. Need an afternoon boost but tired of late-day caffeine keeping you up at night? Caliper Swiftsticks are the answer. Just sprinkle it on your tongue and let it dissolve.

These delightful sweet treats can be kept in the kitchen, handbag, pocket, or suitcase; no measuring, no mess. As always, our products contain 0.0% THC and are GMO-free and vegan.

The water-soluble CBD powder used in our Berry Swiftsticks also features our proprietary Smartsorb™ delivery technology, proven to increase the bioavailability of CBD so that more gets into your system, starting in as little as 10 minutes. Ultimately, this allows four times the amount of CBD to be delivered to your body, versus other brands who typically use an oil-based CBD resulting in very poor absorption.

To purchase NextEvo’s Caliper Berry Swiftsticks, please visit https://nextevo.com/products/berry-swiftstick.

About NextEvo Naturals

NextEvo Naturals is a premium supplement brand that has found a new way to revolutionize the delivery of cannabidiol (CBD) and other nutritional compounds by creating formulations that increase the compound’s potential benefits and consumer value. Led by medical professionals and former scientists from large reputable companies such as Johnson & Johnson, GlaxoSmithKline, and Schiff Nutrition, NextEvo Naturals aims to bridge the gap between the current low-quality CBD offerings on the market and the future of CBD supplements with proprietary technology and evidence-based data.

Stay up-to-date with NextEvo at https://nextevo.com/ as well as on Instagram, Twitter, and Facebook.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

NextEvo Naturals does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Contact Information

Katie Hanna
Content Manager
khanna@nextevo.com
561-685-9613

Lindsey VanderMaas Sobrinski
Director of Ecommerce and Marketing
lsobrinski@nextevo.com
484-336-7013

SOURCE: NextEvo Naturals

View the original press release on newswire.com.

Staff

Recent Posts

Dr. Todd H. Lanman Presented Alignment-Driven Synergy Disc(R) Results and Case Experience at the 2nd Annual Hoag Orthopedic Institute Spine Symposium

Synergy Disc® presentation showcased statistically superior IDE trial outcomes, restoration of cervical lordosis, and long-term…

1 hour ago

From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium

Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion…

1 hour ago

IAVI to Advance Vaccine Candidate for Bundibugyo Virus, Receives Funding from CEPI

WHO identifies rVSV-based candidate as a top priority amid growing Ebola epidemic with no approved…

1 hour ago

Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design

Company highlights streamlined body-map tracking and image management features designed to support long-term skin monitoring…

1 hour ago

Edison Issues Report on Nabaltec (NTG)

London, United Kingdom--(Newsfile Corp. - June 1, 2026) - Edison issues report on Nabaltec (XETRA:…

2 hours ago

Revelation Biosciences Expands Acute Kidney Injury Advisory Board

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB)…

4 hours ago